17 alpha-hydroxylase deficiency epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
===Incidence=== | ===Incidence=== | ||
* The incidencee of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency in the United States is approximately 1 per 100,000 individuals. | * The incidencee of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency in the United States is approximately 1 per 100,000 individuals. | ||
===Age=== | ===Age=== | ||
* Patients of all age groups may develop congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. The mean age of diagnosis is infancy and childhood. | * Patients of all age groups may develop congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. The mean age of diagnosis is infancy and childhood. | ||
===Gender=== | ===Gender=== | ||
* Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency affects male and female equally. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 16:54, 4 February 2016
|
Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
17 alpha-hydroxylase deficiency epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of 17 alpha-hydroxylase deficiency epidemiology and demographics |
|
FDA on 17 alpha-hydroxylase deficiency epidemiology and demographics |
|
CDC on 17 alpha-hydroxylase deficiency epidemiology and demographics |
|
17 alpha-hydroxylase deficiency epidemiology and demographics in the news |
|
Blogs on 17 alpha-hydroxylase deficiency epidemiology and demographics |
|
Risk calculators and risk factors for 17 alpha-hydroxylase deficiency epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Epidemiology and Demographics
Incidence
- The incidencee of congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency in the United States is approximately 1 per 100,000 individuals.
Age
- Patients of all age groups may develop congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency. The mean age of diagnosis is infancy and childhood.
Gender
- Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency affects male and female equally.